Immunological Memory to SARS-CoV-2: Microbial Minutes

Does exposure to SARS-CoV-2 produce immunological memory? If so, how long do those “memories” last, and what are the implications on the development and longevity of vaccine-induced protection?

What's Hot in the Microbial Sciences?

presents Microbial Minutes, a monthly video series of trending topics in the microbial sciences.

The kinetics of immunological memory to SARS-CoV-2 and the behavior of key immunological players involved in those processes are topics that underpin many of the critical questions that continue to circulate about COVID-19 vaccine development. 

Immune memory is the source of protective immunity against future infection. In a broad sense, the term refers to the immune system’s ability to recognize and mount a successful defense against a specific pathogen. Long-term, comprehensive analyses of the kinetics of the consortium of immune cells involved in this process (including antibodies, B cells, CD8+ T cells and CD4+T cells) is necessary to gain perspective about long-term immunity to SARS-CoV-2. 

Here we dive into the research that seeks to explain how the immune system behaves, as it pertains to this virus. The papers and key take-away points discussed in this Microbial Minutes are listed below.

What is immunological memory?

Addetia A. et al. Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate. 

Cox R.J. et al. Not just antibodies: B cells and T cells mediate immunity to COVID-19. 

Sekine T. et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. 

Arnold C. Why antobodies may not be the key to beating coronavirus. 

How long does immunological memory to SARS-CoV-2 last? 

Dan J.M. et al. Immunological memory to SARS-CoV-2 assessed for greater than six months after infection. 

Take-Away Points

  • Development of protective immunity takes time and depends on complex relationships between multiple cellular components that exhibit distinct kinetics and behavior. 
  • SARS-CoV-2-specific T cells have been detected in the absence of circulating antibodies.
  • Durable immunity against SARS-CoV-2 seems to be a possibility in most individuals, and evidence suggests that these immune responses may persist for 6 months or more post infection. 

Author: Ashley Hagen, M.S.

Ashley Hagen, M.S.
Ashley Hagen, M.S. joined the as the Science Communications Specialist in 2020. Today, she is the Scientific and Digital Editor and host of 's Meet the Microbiologist and former host of Microbial Minutes. She earned her Master's Degree in Microbiology from the University of Georgia in Athens, Ga.